Two Additional Patents Issue Covering Advanced Algorithms for Hemodynamic Monitoring
Valhalla, New York (December 19, 2019): Retia Medical, LLC, announced today that two more of its patent applications have issued. These patents, US 10,251,566 and US 10,349,838, expand Retia’s broad coverage in advanced algorithms to enable accurate hemodynamic monitoring of critically ill patients using less invasive sensors. Of note, these patents coverage additional hemodynamic parameters beyond cardiac output that will help critical care practitioners make more informed, data-driven decisions to help manage their patients in circulatory shock.
About the Argos Cardiac Output Monitor
Retia Medical designed the Argos Cardiac Output (CO) Monitor to provide members of the Critical Care team in the operating room and intensive care unit a more accurate, intuitive and affordable hemodynamic monitor that supports confident, data-driven patient care decision making.
Equipped with Retia’s proprietary MBA™ algorithm, which uses advanced signal processing to improve the model of circulation and enables accurate tracking of both fluid and pressor resuscitation, the Argos Monitor seamlessly combines accuracy, ease of use, EMR connectivity and cost-effectiveness.
About Retia Medical
Retia Medical aims to advance the use of CO monitoring to improve patient care by providing members of the critical care team with a more accurate, easy-to-use, and affordable hemodynamic monitor that supports confident, data-driven decisions.
Retia brings together industry-leading expertise in physiology, signal processing, and computational algorithms to engineer innovative monitoring solutions that give clinicians up-to-the-minute data that they can rely on to make informed patient care decisions. Additionally, Retia is committed to offering more clinicians access to CO monitoring by reducing the high per-patient cost and inconvenience that often limit the use of traditional CO technologies to the most high-risk patients. For additional information, please visit www.retiamedical.com.
Contacts
Corporate Contact
Jayne Peister
jpeister@retiamedical.com
(914) 594-1986
Recent Press Releases:
- Retia Medical Announces the acquisition of its Argos hemodynamic monitor by Temple University
- Retia Medical awarded a Hemodynamic Monitoring Products agreement with Premier, Inc.
- Retia Medical and The JANZ Corporation Announce Strategic Partnership Agreement
- Retia Medical presenting at STS, SCCM, and Arab Health!